Charcot Foot Offloading in Stage 0 Is Associated With Shorter Total Contact Cast Treatment and Lower Risk of Recurrence and Reconstructive Surgery: A Pilot Study
Authors' conclusion
Offloading in stage 0 CF was associated with shorter TCC treatment, lower risk of a new CF event, and diminished need for reconstructive surgery. Future amputation risk was not affected.
Study context
- Population
- Patients treated for active Charcot foot at Skåne University Hospital (Lund, Sweden), 2006–2019; median age 61 years, 37% T1D, 62% men183 individuals
- Participants
- 198 analyzed charcot foot (CF) events
- Exposure
- Offloading in stage 0 vs offloading in stage 1 Charcot foot
- Stage 0n = 74
- Stage 1n = 124reference
- Outcome
- Duration of total contact casting (TCC)
Methodological detailssingle-centre, pilot study, Median follow-up 7.0 (IQR 3.9-11) years
- Single-centre
- Pilot study
- Median follow-up 7.0 (IQR 3.9-11) years
Main finding
As reported in the abstract
TCC duration
P = 0.001
Observational data: associations, not effects.
Further findings
New ipsilateral CF events >1 year after definitive footwear
P < 0.05
| Outcome | Stage 0 | Stage 1 | P value |
|---|---|---|---|
| Reconstructive surgery | 0 events | 8.9% | P < 0.01 |
Amputation
- Amputation rates were similar
Original publication
Charcot Foot Offloading in Stage 0 Is Associated With Shorter Total Contact Cast Treatment and Lower Risk of Recurrence and Reconstructive Surgery: A Pilot Study. Diabetes Care. Published 30 November 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →